Journal ArticleOPEN ACCESS

Intralymphatic Injection of Autoantigen in Type 1 Diabetes

  • Ludvigsson J
  • Wahlberg J
  • Casas R
New England Journal of Medicine (2017) 376(7) 697-699
DOI: 10.1056/nejmc1616343
46Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Preserved beta-cell function may improve outcomes in patients with type 1 diabetes. In this pilot trial, residual beta-cell function was preserved in six patients after direct intralymphatic inject...

Cite

CITATION STYLE

APA

Ludvigsson, J., Wahlberg, J., & Casas, R. (2017). Intralymphatic Injection of Autoantigen in Type 1 Diabetes. New England Journal of Medicine, 376(7), 697–699. https://doi.org/10.1056/nejmc1616343

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free